Search
for
Sort by
Research 91–120 of 1000+
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- 1748 IS ANDROGENETIC ALOPECIA ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA? ANALYSIS OF 907 PATIENTS
- Prostate Specific Antigen as Predictive Factor for Androgenemia in Women
- Comparative Effect of Finasteride and Dutasteride on Chromogranin A Levels
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Editorial Comment
- Daily subcutaneous testosterone for management of testosterone deficiency
- The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy
- Hormonal treatment for male-pattern hair loss: implications for cancer of the prostate?
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Safety and Efficacy Assessment of Red Ginseng Oil (RXGIN) in Men with Lower Urinary Tract Symptoms in a Randomized, Double-Blind, Placebo-Controlled Trial
- Hormone therapy in acne
- Study of Frontal Hairline Patterns in Spanish Caucasian Women
- Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis
- Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia
- Finasteride-its impact on sexual function and prostate cancer
- Adult Male Hypogonadism: A Laboratory Medicine Perspective on Its Diagnosis and Management
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–II
- Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines
- Investigation, treatment and monitoring of late‐onset hypogonadism in males: ISA, ISSAM, and EAU recommendations
- Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians
- Economic Issues in the Treatment of BPH
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- Patient-reported outcomes, provider-reported outcomes, and physiologic parameters after gender-affirming hormone treatment in Canada: a systematic review
- Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
- Prostate cancer update: 2007
- Intracrinology and Testosterone Pellet Therapy: An Enzyme-Aware, Symptom-Driven Approach to Hormone Optimization in Aging
- 9 Pilosebaceous physiology in relation to hirsutism and acne
- Polymorphisms in androgen and estrogen receptor genes: effects on male aging